www.fdanews.com/articles/113567-europe-approves-enbrel-for-psoriasis-in-children
Europe Approves Enbrel for Psoriasis in Children
January 8, 2009
Wyeth’s established drug Enbrel has been approved by the European Commission as the first biologic treatment for children with severe plaque psoriasis, the U.S. company said.
CNBC
CNBC